Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01786525 · ClinicalTrials.gov registry record · NA

House Calls and Decision Support: Improving Access to Live Donor Transplantation

A NA study, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
NA
Development phase
109
Enrollment target

NCT01786525 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 109 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01786525, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
NA
Development phase
109 participants
Enrollment target

Study Summary

The main purpose of this research program is to reduce the burden of end-stage organ disease on individuals, families, healthcare systems, and society by increasing the availability of donor organs for transplantation. Consistent with this aim, the project further examines strategies to increase access to and reduce disparities - racial, economic, gender - in live donor kidney transplantation (LDKT). Specifically, we expand the research and intensity of an innovative House Calls intervention developed by the principal investigator by including other minorities and socioeconomically disadvantaged patients and by adding a novel Patient-Centered Decision Support component. The main study hypothesis is that participants receiving the novel intervention (House Calls + Patient-Centered Decision Support) will have a higher proportion of LDKT's by the 2-year study endpoint.

Interventions

  • BEHAVIORAL House Calls
  • BEHAVIORAL Web-Based Patient-Centered Decision Support Intervention

Trial Details

FieldValue
Enrollment Target 109 participants
Start Date 2013-06
Est. Completion 2020-05-31
Phase NA

What the Registry Record Tells You About NCT01786525

The ClinicalTrials.gov registry entry for NCT01786525 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which House Calls is the first listed.

NCT01786525 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01786525 about?

NCT01786525 is a clinical study titled "House Calls and Decision Support: Improving Access to Live Donor Transplantation". The main purpose of this research program is to reduce the burden of end-stage organ disease on individuals, families, healthcare systems, and society by increasing the availability of donor organs for transplantation. Consistent with this aim, the project further examines strategies to increase acc...

What is the current status of trial NCT01786525?

This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2013-06. Estimated completion is 2020-05-31.

What interventions are being tested in trial NCT01786525?

The interventions under investigation include: House Calls (BEHAVIORAL), Web-Based Patient-Centered Decision Support Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01786525?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.